(Q44876995)

7 December 2017

0 references

Unraveling the potential of CRISPR-Cas9 for gene therapy (English)

1 reference

7 December 2017

0 references

0 references

0 references

1

1 reference

7 December 2017

2

Andrew P May

1 reference

7 December 2017

language of work or name

English

0 references

publication date

23 December 2014

1 reference

Expert Opinion on Biological Therapy

7 December 2017

published in

1 reference

7 December 2017

volume

15

1 reference

7 December 2017

issue

3

1 reference

7 December 2017

page(s)

311-314

1 reference

CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

CRISPR-Cas systems for editing, regulating and targeting genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

Cas9 as a versatile tool for engineering biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

Correction of a genetic disease in mouse via use of CRISPR-Cas9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

CRISPR-mediated direct mutation of cancer genes in the mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

CRISPR-Cas9 knockin mice for genome editing and cancer modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.994501

10.1517/14712598.2015.994501

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference